Race Oncology Ltd (ASX:RAC) CEO Damian Clarke-Bruce joined Steve Darling from Proactive to talk about him being named as the company’s new managing director/CEO. Clarke-Bruce talks about his background which includes executive roles at all stages of the drug development process, from pre-clinical evaluation through to successful commercial launch. Clarke-Bruce also share his reasons behind taking the job and what his first order of business will be.
Race Oncology welcomes veteran Damian Clarke-Bruce as managing director/CEO
